Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 162 participants.
Also called NCT07687212
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 162 participants
- Registry
-
NCT07687212
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07687212. Randomized; quadruple masking; primary purpose treatment. Start 2026-07 (anticipated); primary completion 2027-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF
- Condition
- Heart Failure, Preserved Ejection Fraction
- Intervention (Drug)
- Henggliflozin Combined with Probiotics
- Intervention (Drug)
- Henggliflozin
- Intervention (Drug)
- double placebo
- Lead sponsor
- The First Affiliated Hospital of Air Force Medical University
Record details
- Record id
cardio:ct-nct07687212- Content hash
8c48379cf94ff44c8ed3dccdc27b34ae46c0ced728518981a103fa8a3eb098b6